(Q44934503)

7 December 2017

title

The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis (English)

1 reference

7 December 2017

0 references

Kwi Young Kang

1

1 reference

7 December 2017

Ji Hyeon Ju

series ordinal

2

1 reference

7 December 2017

Sung-Hwan Park

series ordinal

3

1 reference

7 December 2017

Ho-Youn Kim

series ordinal

4

1 reference

7 December 2017

publication date

28 December 2012

1 reference

7 December 2017

1 reference

7 December 2017

volume

52

1 reference

7 December 2017

issue

4

1 reference

7 December 2017

page(s)

718-726

1 reference

Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES364

Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES364

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES364

Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES364

Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES364

Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES364

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES364

Disease modification in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES364

Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES364

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES364

Appendicular and vertebral bone mass in ankylosing spondylitis. A comparison of plain radiographs with single- and dual-photon absorptiometry and with quantitative computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES364

Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES364

Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES364

The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES364

The relationship between inflammation and new bone formation in patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES364

Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKES364

10.1093/RHEUMATOLOGY/KES364

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference